A Safety And Efficacy Study Of Alg-1001 In Human Subjects With Symptomatic Focal Vitreomacular Adhesion

Study of Intravitreal Aflibercept Injection for Persistent CRVO-associated Macular Edema Despite Prior Anti-VEGF Therapy

NCT01857544 ·Status: UNKNOWN ·Phase: PHASE4

Dose Escalation Study to Evaluate the Safety/Tolerability and Efficacy of EA-2353 in Subjects With Retinitis Pigmentosa

NCT05392751 ·Status: TERMINATED ·Phase: PHASE1/PHASE2

A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion

NCT01889251 ·Status: COMPLETED ·Phase: PHASE3

Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)

NCT01722045 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate Abicipar Pegol for Safety and Treatment Effect in Participants With Neovascular Age-related Macular Degeneration (AMD)

NCT03539549 ·Status: COMPLETED ·Phase: PHASE2

Long-term Follow-up Study of AL-001 Ophthalmic Injection in Subjects with WAMD

NCT06718816 ·Status: RECRUITING

A Safety and Efficacy Study of E10030 (Anti-PDGF Pegylated Aptamer) Plus Lucentis for Neovascular Age-Related Macular Degeneration

NCT01089517 ·Status: COMPLETED ·Phase: PHASE2

Safety and Efficacy of AGN208397 in the Treatment of Macular Edema Associated With Retinal Vein Occlusion (RVO)

NCT01027650 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Randomized, Single-Masked, Long-Term, Safety and Tolerability Study of VEGF Trap-Eye in AMD

NCT00527423 ·Status: COMPLETED ·Phase: PHASE2

Study of Bimonthly VEGF Trap-Eye Compared to As-needed Administration or Other Therapy for Exudative Age-Related Macular Degeneration

NCT01526070 ·Status: COMPLETED

Safety and Efficacy of Intravitreal LFG316 in Wet Age Related Macular Degeneration (AMD)

NCT01535950 ·Status: COMPLETED ·Phase: PHASE2

A Study to Learn How Well Aflibercept Injected Into the Eye Works and How Safe it is When Given in Customized Treatment Intervals in Patients With an Eye Disease Called Neovascular Age-related Macular Degeneration After Start of Treatment

NCT05473715 ·Status: TERMINATED ·Phase: PHASE4

To Evaluate The Role of Intravitreal Aflibercept Injection (2.0 mg) in the Management of Previously Treated Patients With Exudative AMD

NCT01495221 ·Status: COMPLETED ·Phase: PHASE4

Safety and Efficacy Study of Intravitreal Ocriplasmin in Subjects With AMD With Focal Vitreomacular Adhesion

NCT00913744 ·Status: COMPLETED ·Phase: PHASE2

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

NCT06942572 ·Status: RECRUITING ·Phase: PHASE1/PHASE2

Vascular Endothelial Growth Factor (VEGF) Trap-Eye: Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration (AMD)

NCT00637377 ·Status: COMPLETED ·Phase: PHASE3

EYE001 to Treat Retinal Tumors in Patients With Von Hippel-Lindau Syndrome

NCT00056199 ·Status: COMPLETED ·Phase: PHASE1

Sirolimus Versus Anti-Vascular Endothelial Growth Factor (antiVEGF) for Wet AMD

NCT02357342 ·Status: COMPLETED ·Phase: PHASE2

A Study Investigating the Safety and Efficacy of Lampalizumab Intravitreal Injections in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

NCT02247531 ·Status: TERMINATED ·Phase: PHASE3

Efficacy and Safety of AL-001 Ophthalmic Injection in Subjects with WAMD

NCT06839339 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

Study of Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

NCT03481634 ·Status: COMPLETED ·Phase: PHASE3

A Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy Secondary to Age-related Macular Degeneration

NCT04615325 ·Status: COMPLETED ·Phase: PHASE1

A Study in Patients With Wet Age-related Macular Degeneration or Diabetic Macular Edema to Assess the freQuency of Use of Intravitreal Aflibercept in Routine Clinical Practices in Latin America

NCT03470103 ·Status: COMPLETED

Safety and Efficacy of a New Treatment as Adjunctive Therapy to Anti-vascular Endothelial Growth Factor (Anti-VEGF) Treatment in Patients With Age-Related Macular Degeneration (AMD)

NCT00511706 ·Status: COMPLETED ·Phase: PHASE2

Study of MP0112 Intravitreal Injection in Patients With Wet Age Related Macular Degeneration

NCT01086761 ·Status: TERMINATED ·Phase: PHASE1